Independent research & country-by-country guides · Information is not a substitute for medical care
Research · Compare · Explore
Southeast Asia · Local access

GLP-1 access guides for six Asian countries

Choose a country to check official regulator resources, browse source-linked clinics and plan the full cost of consultations, tests and treatment.

Source review: October 2026·No unsourced product-approval or pricing claims

Choose your country

How GLP1Asia approaches country-specific questions

Medicine authorisation, specialist access and healthcare fees can differ across countries. Rather than assuming a prescription is available throughout Asia, each guide links to the national regulatory starting point and explains the questions a visitor should ask of a licensed provider.

We distinguish the cost of a medical screening programme from a medication price, and we do not infer product approval from marketing language or a clinic’s general weight-management page. For context on treatment classes, read our semaglutide and tirzepatide guides.

Automated source monitoring is not regulatory verification. Source changes and failed requests are held for editorial checking instead of automatically becoming new clinical claims.

Continue with LINE

Your LINE link opens a personal profile and cannot prefill a direct message. Copy this prepared enquiry, open LINE, then paste it into the chat.